Your browser doesn't support javascript.
loading
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism.
García-Silva, Susana; Benito-Martín, Alberto; Nogués, Laura; Hernández-Barranco, Alberto; Mazariegos, Marina S; Santos, Vanesa; Hergueta-Redondo, Marta; Ximénez-Embún, Pilar; Kataru, Raghu P; Lopez, Ana Amor; Merino, Cristina; Sánchez-Redondo, Sara; Graña-Castro, Osvaldo; Matei, Irina; Nicolás-Avila, José Ángel; Torres-Ruiz, Raúl; Rodríguez-Perales, Sandra; Martínez, Lola; Pérez-Martínez, Manuel; Mata, Gadea; Szumera-Cieckiewicz, Anna; Kalinowska, Iwona; Saltari, Annalisa; Martínez-Gómez, Julia M; Hogan, Sabrina A; Saragovi, H Uri; Ortega, Sagrario; Garcia-Martin, Carmen; Boskovic, Jasminka; Levesque, Mitchell P; Rutkowski, Piotr; Hidalgo, Andrés; Muñoz, Javier; Megías, Diego; Mehrara, Babak J; Lyden, David; Peinado, Héctor.
Afiliación
  • García-Silva S; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Benito-Martín A; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA.
  • Nogués L; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Hernández-Barranco A; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Mazariegos MS; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Santos V; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Hergueta-Redondo M; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Ximénez-Embún P; Proteomics Unit, ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Kataru RP; Department of Surgery, Plastic and Reconstructive Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Lopez AA; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Merino C; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Sánchez-Redondo S; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Graña-Castro O; Bioinformatics Unit, Structural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Matei I; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA.
  • Nicolás-Avila JÁ; Area of Developmental and Cell Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Torres-Ruiz R; Molecular Cytogenetics Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Rodríguez-Perales S; Molecular Cytogenetics Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Martínez L; Flow Cytometry Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Pérez-Martínez M; Cofocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Mata G; Cofocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Szumera-Cieckiewicz A; Department of Pathology and Laboratory Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Kalinowska I; Diagnostic Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Saltari A; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Martínez-Gómez JM; Department of Dermatology, University of Zurich, University of Zurich Hospital, Zurich, Switzerland.
  • Hogan SA; Department of Dermatology, University of Zurich, University of Zurich Hospital, Zurich, Switzerland.
  • Saragovi HU; Department of Dermatology, University of Zurich, University of Zurich Hospital, Zurich, Switzerland.
  • Ortega S; Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
  • Garcia-Martin C; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
  • Boskovic J; Transgenic Mice Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Levesque MP; Electron Microscopy Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Rutkowski P; Electron Microscopy Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Hidalgo A; Department of Dermatology, University of Zurich, University of Zurich Hospital, Zurich, Switzerland.
  • Muñoz J; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Megías D; Area of Developmental and Cell Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Mehrara BJ; Proteomics Unit, ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Lyden D; Cofocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
  • Peinado H; Department of Surgery, Plastic and Reconstructive Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mehrarab@mskcc.org.
Nat Cancer ; 2(12): 1387-1405, 2021 12.
Article en En | MEDLINE | ID: mdl-34957415
ABSTRACT
Secreted extracellular vesicles (EVs) influence the tumor microenvironment and promote distal metastasis. Here, we analyzed the involvement of melanoma-secreted EVs in lymph node pre-metastatic niche formation in murine models. We found that small EVs (sEVs) derived from metastatic melanoma cell lines were enriched in nerve growth factor receptor (NGFR, p75NTR), spread through the lymphatic system and were taken up by lymphatic endothelial cells, reinforcing lymph node metastasis. Remarkably, sEVs enhanced lymphangiogenesis and tumor cell adhesion by inducing ERK kinase, nuclear factor (NF)-κB activation and intracellular adhesion molecule (ICAM)-1 expression in lymphatic endothelial cells. Importantly, ablation or inhibition of NGFR in sEVs reversed the lymphangiogenic phenotype, decreased lymph node metastasis and extended survival in pre-clinical models. Furthermore, NGFR expression was augmented in human lymph node metastases relative to that in matched primary tumors, and the frequency of NGFR+ metastatic melanoma cells in lymph nodes correlated with patient survival. In summary, we found that NGFR is secreted in melanoma-derived sEVs, reinforcing lymph node pre-metastatic niche formation and metastasis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vesículas Extracelulares / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vesículas Extracelulares / Melanoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2021 Tipo del documento: Article País de afiliación: España